Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India

International Journal of Rheumatic Diseases
Vineeta ShobhaK R Anupama

Abstract

Tuberculosis (TB) is one of the major adverse events of concern associated with the use of biologics for managing autoimmune inflammatory rheumatic diseases (AIRDs). The study presents the data on incidence of TB in relation to biologic used, screening test and TB prophylaxis in a real-world setting. The cross-sectional, observational, retrospective study was conducted across 12 centres in Karnataka, India. The study included patients receiving biologics therapy for AIRDs, established based on the respective diagnostic criteria. The development of TB after receiving biologic therapy and other clinical variables and the predictability of the test performed for latent TB were evaluated. One hundred and ninety-five AIRDs patients with an average age of 41 years were initiated on biologic therapy. Twenty-one patients were latent TB positive and were given antitubercular prophylaxis, prior to biologics treatment. During follow-up, seven patients belonging to the negative test group (n = 174) developed TB. The negative predictive values noted for Mantoux test (n = 120) and quantiFERON TB gold test (n = 178) were 96.52% and 96.25%, respectively. Patients on anti-tumor necrosis factor were more likely to develop TB. Presence of comorbi...Continue Reading

References

Mar 1, 1992·The American Review of Respiratory Disease·R Menzies, B Vissandjee
Jun 4, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Xi XieJia Wang
Jul 28, 2013·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Bridget HodkinsonUNKNOWN South African Rheumatism and Arthritis Association
Mar 13, 2015·Rheumatology International·Juan Carlos Cataño, Milena Morales
Dec 22, 2016·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Nhu Quynh TranLaura Carbone
Jan 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M LewinsohnGail L Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.